Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Bertrand

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
FEMS Microbiology Ecology|September 23, 2021
Cropping systems impact changes in soil fungal, but not prokaryote, alpha-diversity and community composition stability over a growing season in a long-term field trialDamien R Finn, Sungeun Lee, Anders Lanzén, et al.
Ultrasound in Medicine & Biology|February 15, 2005
Monitoring the formation of thermal lesions with heat-induced echo-strain imaging: a feasibility studyRémi Souchon, Guillaume Bouchoux, Eva Maciejko, et al.
Cardiovascular Drugs and Therapy|October 22, 2008
Secondary prevention of coronary disease with ACE inhibition--does blood pressure reduction with perindopril explain the benefits in EUROPA?Willem J Remme, Jaap W Deckers, Kim M Fox, et al.
Journal of the Mechanical Behavior of Biomedical Materials|February 5, 2014
Cap buckling as a potential mechanism of atherosclerotic plaque vulnerabilityMaria Abdelali, Steven Reiter, Rosaire Mongrain, et al.
International Journal of Cardiology|January 9, 2015
Impact of renin-angiotensin system inhibitors on mortality and major cardiovascular endpoints in hypertension: A number-needed-to-treat analysisJasper J Brugts, Laura van Vark, Martijn Akkerhuis, et al.
European Heart Journal|April 19, 2012
Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patientsLaura C van Vark, Michel Bertrand, K Martijn Akkerhuis, et al.
Molecules (Basel, Switzerland)|July 15, 2017
Specialized Metabolites of the Lichen Vulpicida pinastri Act as Photoprotective AgentsBéatrice Legouin, Françoise Lohézic-Le Dévéhat, Solenn Ferron, et al.
Journal of the American College of Cardiology|November 27, 2007
The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trialJasper J Brugts, Eric Boersma, Michel Chonchol, et al.
European Heart Journal|February 25, 2006
Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of riskJaap W Deckers, Dick M Goedhart, Eric Boersma, et al.
Heart (British Cardiac Society)|December 1, 2006
Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA studyAndrew Briggs, Borislava Mihaylova, Mark Sculpher, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
FEMS Microbiology Ecology|September 23, 2021
Cropping systems impact changes in soil fungal, but not prokaryote, alpha-diversity and community composition stability over a growing season in a long-term field trialDamien R Finn, Sungeun Lee, Anders Lanzén, et al.
Ultrasound in Medicine & Biology|February 15, 2005
Monitoring the formation of thermal lesions with heat-induced echo-strain imaging: a feasibility studyRémi Souchon, Guillaume Bouchoux, Eva Maciejko, et al.
Cardiovascular Drugs and Therapy|October 22, 2008
Secondary prevention of coronary disease with ACE inhibition--does blood pressure reduction with perindopril explain the benefits in EUROPA?Willem J Remme, Jaap W Deckers, Kim M Fox, et al.
Journal of the Mechanical Behavior of Biomedical Materials|February 5, 2014
Cap buckling as a potential mechanism of atherosclerotic plaque vulnerabilityMaria Abdelali, Steven Reiter, Rosaire Mongrain, et al.
International Journal of Cardiology|January 9, 2015
Impact of renin-angiotensin system inhibitors on mortality and major cardiovascular endpoints in hypertension: A number-needed-to-treat analysisJasper J Brugts, Laura van Vark, Martijn Akkerhuis, et al.
European Heart Journal|April 19, 2012
Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patientsLaura C van Vark, Michel Bertrand, K Martijn Akkerhuis, et al.
Molecules (Basel, Switzerland)|July 15, 2017
Specialized Metabolites of the Lichen Vulpicida pinastri Act as Photoprotective AgentsBéatrice Legouin, Françoise Lohézic-Le Dévéhat, Solenn Ferron, et al.
Journal of the American College of Cardiology|November 27, 2007
The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trialJasper J Brugts, Eric Boersma, Michel Chonchol, et al.
European Heart Journal|February 25, 2006
Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of riskJaap W Deckers, Dick M Goedhart, Eric Boersma, et al.
Heart (British Cardiac Society)|December 1, 2006
Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA studyAndrew Briggs, Borislava Mihaylova, Mark Sculpher, et al.
Pageof 5